ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

GSK Gsk Plc

1,653.00
12.50 (0.76%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  12.50 0.76% 1,653.00 1,654.00 1,655.00 1,655.50 1,634.00 1,638.50 3,990,601 16:35:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.83 68.14B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,640.50p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £68.14 billion. Gsk has a price to earnings ratio (PE ratio) of 13.83.

Gsk Share Discussion Threads

Showing 25051 to 25073 of 33100 messages
Chat Pages: Latest  1012  1011  1010  1009  1008  1007  1006  1005  1004  1003  1002  1001  Older
DateSubjectAuthorDiscuss
25/2/2021
16:30
It's time that GSK went into medicinal cannabis products! Just look at MXC and KNB and the debut of Cellular Goods tomorrow. I wonder if this possibility has had any serious consideration??????????
fez77
25/2/2021
16:21
Will let you know when I finished buying, something I spotted.
montyhedge
25/2/2021
16:19
Spud I reckon GSK could have a 5 billion bonus up they sleeve, early days yet.
montyhedge
25/2/2021
16:17
Does it matter no profit in covid vaccine anyway, ask Astra.
montyhedge
25/2/2021
15:44
GlaxoSmithKline Covid-19 Antibody Study Didn't Meet Primary Endpoint

25/02/2021 12:29pm
Dow Jones News


GlaxoSmithKline PLC said Thursday that a phase-2 trial evaluating the use of a monoclonal antibody in Covid-19 patients didn't meet the primary endpoint when tested on patients of all ages.

The drug, which is named otilimab, failed to achieve significant improvements in keeping patients free of respiratory failure 28 days after treatment when paired with the existing standard of care, the British pharmaceutical giant said.

The study, however, did prove that treatment with otilimab was effective in patients 70 years and older when combined with the existing standard of care.

As a result, the company said it will amend the study to expand its investigation in this age group and confirm the findings.

spud

spud
25/2/2021
15:01
I'm in seems a good price.
Could go lower of course but you never know.
Average PE of FTSE100 companies that have a PE tends to be about 20
So potentially price could double.
Or alternatively profits could half.

netcurtains
25/2/2021
14:57
Azn p/e 40.7Gsk p/e 10.5Based on 2020 fy results eps and current share price.
coxsmn
25/2/2021
14:47
Mainly down to (Miss) Management (aka EW). spud
spud
25/2/2021
13:46
sp valuation gap between gsk and azn is astounding
coxsmn
25/2/2021
11:27
Ah cheers mate.
This Test sounds a blast.

geckotheglorious
25/2/2021
11:27
More4 from 1pm. Shows 1 day behind unfortunately.

spud

spud
25/2/2021
11:25
Montie,
Why are you bashing Buywell3 for being on the wrong thread when you persistently repeat yourself on the AZN thread!
Do everyone a favour and keep your comments here where it is percieved that you may have a holding for income?
It would be good manners if you stopped mocking people for losing money on AZN, especially 'the boys that bought at 9,200'
No need for it at all.

beckers2008
25/2/2021
11:24
Goodness me.

Where's the best place to watch the highlights please spud?

geckotheglorious
25/2/2021
11:23
Should have had a spoiler alert on that! Was planning on watching highlights this PM.

spud

spud
25/2/2021
11:12
It looks like the wicket has exploded. Lots of sand/dry mud forming pot holes. England lost 2 wickets already
tradermichael
25/2/2021
10:52
TraderMichael.
Wow India 11/7 for 6..England all out for smalls..

What's wrong with the pitch they're currently playing on?

Is it very humid/wet where they are?

geckotheglorious
25/2/2021
09:54
Nice to see though TM!
spyder
25/2/2021
09:43
Sorry, wrong thread!
tradermichael
25/2/2021
09:43
India 117 for 6
tradermichael
25/2/2021
08:37
Your on the wrong thread. This is GSK not Astra.
montyhedge
25/2/2021
08:02
Looks like Covid-19 Variants are here to stay so :

AZN are looking at using nasal spray vaccines ( like flu)
Also oral vaccine tablets
Also vaccine skin patches


Strain on NHS resources re vaccinations continuance twice or thrice yearly is clearly not going to be a workable option in a year round 24/7 Covid-19 world

buywell3
25/2/2021
07:31
FTSE 100 spreads showing decent pre- trading gains for the first time since we found a 1200 floor ( to add to a decent session yesterday afternoon and across the pond) . If GSK wants to find escape velocity from 1200 it better make a move this morning after several failures earlier this week.
stewart64
24/2/2021
20:21
The correlation between AZN and GSK recently is there to see

It is currently a SECTOR problem

The massive amount of work and costs associated with manufacturing vaccines for Covid at prices the world can afford is imo hurting other lines and perhaps some are seeing this continuing

Plus Debts are now seen as a future problem

buywell2
Chat Pages: Latest  1012  1011  1010  1009  1008  1007  1006  1005  1004  1003  1002  1001  Older

Your Recent History

Delayed Upgrade Clock